Title: Prenatal and Postnatal Growth and Endocrine Diseases
1Prenatal and Postnatal Growth and Endocrine
Diseases
Department of Pediatrics
University of Chieti, Italy
2 Francesco Chiarelli is Professor of
Pediatrics and Pediatric Endocrinology
at the Department of Pediatrics,
University of Chieti, Italy His field of
research is diabetes mellitus in
children, with reference to early
detection and prevention of vascular
complications Professor Chiarelli published
numerous papers on ranked international journals
and has been invited as speaker at many meetings
around the world He has recently been appointed
as both Chairman of ISPAD Scientific Committee
(International Society for Pediatric and
Adolescent Diabetes)(2002-2004) and Secretary
General of ESPE (European Society for Paediatric
Endocrinology)(2004-2007)
3 1. Definition and causes of IUGR2. Growth and
growth factors3. Insulin-resistance4.
Adrenals5. Gonads
4 1. Definition and causes of IUGR2. Growth and
growth factors3. Insulin-resistance4.
Adrenals5. Gonads
5 IUGR definition
Pathological decrease of fetal growth
Birth weight lt 10th (or 5th) percentile for
gestational age
Birth weight lt 2.5 Kg for gestational age of ?
37 weeks
Birth weight lt 2SD below the mean value for
gestational age
6Definition of Small for Gestational Age (SGA)
- Birth weight and/or length of 2 or more standard
deviations (SD) below the mean for gestational
age and sex
7IUGR and SGA newborns Definition of clinical
conditions at birth secondary to birth length
(height) or birth weight according to gestational
age
Birth Length
Below 2 SD Normal
Greater than 2SD
(IUGR or SGA)
Birth weight overweight
overweight
macrosomic greater than 2SD IUGR1
proportionate
(or SGA2)
or symmetrical
Birth weight IUGR1
normal eutrophic
normal (or
SGA2) or proportionate
Birth weight proportionate
SGA1
hypotrophic below -2 SD
(symmetrical) or
hypotrophic tall newborn
(SGA2)
SGA2
Chatelain P, Endocrine Regulation 2000
1 IUGR is defined by birth length
2 SGA is defined by both birth length or birth
weight
8Boy, 5.2 years old. He is 95.3 cm tall and weighs
11.9 kg, which is 4.2 SD score below the mean.
His birth weight was 2,160 grams, which is 2.59
SD scores below the mean. His physical appearance
is typical of SGA children showing a
triangular-shaped face with a relatively large
head and high forehead, a very lean body mass
which is especially evident in his thinner than
usual arms and legs. Courtesy of Dr. Anita
Hoekken-Koelega
9What are the causes of SGA?
- Maternal
- Vascular disease
- Environmental
- factors
- Infection
- Nutrition
- Fetal
- Genetic abnormalities
- Congenital malformations
- Metabolic problems
- Multiple gestations
- Placental
- Insufficiency
- Abruption
- Infarction
- Vascular abnormalities
- Demographic
- Maternal age and height
- Fathers size
- Obstetric history
- Race
10IUGR phenotypes
- Symmetrical IUGR (20-30)
- Proportionate reduction of all fetal mesurements
- Aetiology intrinsic alteration in growth
potential or severe nutritional deprivation
overwhelming protective brain-sparing mechanism
occuring prior to 26 weeks nd persisting until
delivery - Asymmetrical IUGR (70-80)
- Disproportionate reduction of fetal mesurements
due to uteroplacental insufficiency with
preferential shunting of blood to fetal brain - High HC/AC FL/AC
11 IUGR short-term consequences
Increased perinatal morbidity and mortality
- 6-8 fold increase for intrapartum and neonatal
death - Respiratory distress
- Necrotizing enterocolitis
- Meconium aspiration
- Electrolyte imbalance
- Polycythemia
- Intraventricular hemorrhage
12 IUGR long-term consequences
- Short stature
- Cardiovascular disease
- Hypertension
- Metabolic disease (T2DM)
- Obesity
- Osteoporosis
13 1. Definition and causes of IUGR2. Growth and
growth factors3. Insulin-resistance4.
Adrenals5. Gonads
14 Catch-up growth in IUGR
Preterm
Fullterm
100 -
80 -
Percentage ()
60 -
40 -
20 -
0
3
6
12
24
Age (months)
Hokken-Koelega A, Pediatr Res 1995
15Postnatal growth in children born SGA
Karlberg J, Albertsson-Wikland K. Pediatr Res
1995387339.
16 The Concept of CRITICAL WINDOW
Critical window
Trait
Fetal life
Infancy
Adulthood
Time
Welles J.C.K. J.Ther.Biol. 2003
17 PRENATALLY
Poor maternal nutrition
Poor placental function
Low maternal fat stores
Nutrient demand gt placental supply
Fetal Undernutrition
Hormonal and metabolic adaptations in utero
GH
IGF system switched-off
Amino acid oxidation
IGF-1
insulin
Lactate oxidation
Glucose oxidation
cortisol
Fetal programming
Survival and development of vital organs (i.e
brain)
IUGR
18 The regulation of fetal growth
IGF-II
Early gestation
GH
IGFBP-1
IGF-I
IGFBP-3
Late gestation
Insulin
Glucose and amino acid availability
19GH-IGF axis
-
Hypothalamus
GHRH
Somatostatin
Ghrelin
Stomach
Pituitary
-
-
GH receptor
GHBP
GH
IGF-1
Autocrine
Paracrine
IGF-1
Target tissues
Endocrine
Liver
IGFBP and ALS
IGF receptor
Trends Endocrinol Metab, 2002
20The regulation of fetal growth
Normal glucose and amino acid availability
IGFBP-1
IGFBP-3
GH
IGF-I
Insulin
GROWTH
Normal glucose transport in muscle and brain
21 Fetal salvage hypothesis
Reduced glucose and amino acid availability
IGFBP-1
IGFBP-3
GH
Insulin
IGF-I
IUGR
Reduced glucose transport in muscle and normal in
brain
22 Fetal salvage hypothesis
Glucose transport
Brain tissue
Lung tissue
Glial cells
Fibroblasts
Type II
Control
Simmons R, Pediatr Res 1992
23 Fetal insulin hypothesis
Maternal glucose concentration
Glucose sensing by fetal pancreas
Fetal genetics
Insulin secretion by fetal pancreas
Fetal insulin resistance
Insulin-mediated growth of fetus
Birthweight
24 Glucose challenge in fetuses
Glucose (mmol/L)
IUGR
Control
Insulin mU/L)
Time (min)
Nicolini U, Horm Metab Res 1990
25 Hormone levels in fetuses
IGF-I (mcg/L)
IGFBP-3 (mcg/L)
Insulin (mcU/ml)
IGFBP-1 (mcg/L)
IUGR
Control
Langford KS, J Clin Endocrinol Metab 1994
26Reprogramming of the GH-IGF axis in IUGR
Hypothalamus
GHRH
Somatostatin
-
-
Ghrelin
Enhanced negative feedback
Stomach
Pituitary
-
Alterated target tissue GH resistance
-
-
GH receptor
Hepatic GH resistance
Liver
Target tissues
GHBP
GH
IGF-1
Insulin
IGF-1
-
IGF resistance
IGFBP-1
IGF receptor
Trends Endocrinol Metab, 2002
27 POSTNATALLY
Adequate Nutrient Supply
Catch-up Growth
IGF system switched-on
insulin production
Insulin like action
Insulin Resistance
IGFBP-3 fragment
GH Resistance
A. Mohn, F. Chiarelli, mod., 2002
28 Glucose challenge in newborn
Glucose infusion (2.6-4.6 mg/kg/min)
Glucose mg/dl
Control
IUGR
Insulin mU/L
Time (min)
Kalhan SC, Pediatr Res 1995
29 Hormone levels in newborns
IGF-I (mcg/L)
Insulin (mU/L)
IGFBP-3 (mcg/L)
IGFBP-1 (mcg/L)
GH (mcg/L)
Control
IUGR
de Zegher F, Acta Paediatr 1997
30Hormone levels in IUGR from birth to 24 mo of age
GH
Time (months)
IGF-1
IGFBP-3
1.2 ?0.9
46?44
32 ?21
IUGR
0
85 ?36
1.5 ?0.4
Control
19 ?9
IUGR
12?8
1
79?33
1.8?0.5
Control
10?8
90?35
1.7?0.7
2.3 ?0.7
6.1?3.5
81 ?37
IUGR
6
Control
3.4?2.4
102?36
2.1?0.6
IUGR
2.6 ?0.8
3.8?4.2
89 ?34
12
Control
2.7?2.2
73?35
2.1?0.4
2.7 ?0.6
2.6?2.5
98 ?44
IUGR
24
Control
2.2?1.6
80?29
2.6?0.6
Values are mean ? SD
Leger J, Pediatr Res 2001
31Hormone levels in IUGR with and without catch-up
growth
Time (months)
GH
IGF-1
IGFBP-3
1.2 ?1.6
63?90
28 ?18
lt - 2 SDS
0
31 ?21
1.1 ?0.9
48?43
gt - 2 SDS
lt - 2 SDS
1
15?7
80?26
1.4?0.2
74?34
1.8?0.5
15?11
gt - 2 SDS
4?2
75 ?41
1.9 ?0.5
lt - 2 SDS
6
2.3?0.7
7?10
81 ? 36
gt - 2 SDS
2.3 ?0.3
4?3
74 ?26
lt - 2 SDS
12
2.7?0.8
4?4
89?35
gt - 2 SDS
50 ?18
3?3
2.2 ?0.5
lt - 2 SDS
24
gt - 2 SDS
3?3
101?43
2.8?0.6
Leger J, Pediatr Res 2001
Values are mean ? SD
32 Hormone levels in infants
IGF-I (mcg/L)
IGFBP-3 (mcg/L)
IGFBP-1 (mcg/L)
Beta cell function
Insulin (mU/L)
Insulin sensitivity
IUGR
Control
Woods KA, Pediatr Res 2002
33 Fetal insulin hypothesis
Maternal glucose concentration
Glucose sensing by fetal pancreas
Fetal genetics (IGF-1,GK,insulin, etc.)
Insulin secretion by fetal pancreas
Fetal insulin resistance
Insulin-mediated growth of fetus
Birthweight
34Overnight GH secretion in infancy
IUGR group (n13)
Control group (n 15)
p value (t test)
GH (mUI/l)
Maximum
55.9 (30.4-80.5)
39.6 (15.6-75.9)
0.1
Mean
13.1 (7.2 19.1)
8.9 (3.7-18.5)
0.004
Minimum
1.2 (lt0.4-2.1)
0.6 (0.5-1.3)
0.004
No. of pulses
5.4 (3-7)
4.3 (3-8)
0.02
Area under curve
115.8 (62-171.1)
84.1 (28.7-165.8)
0.02
0.12
Pulse amplitude
25.2 (17.4-36.7)
20.6 (9.1-40.8)
Values are mean and range
Woods KA, Mohn A, Pediatr Res 2002